Adipose‐Derived stem cells: current applications and future directions in the regeneration of multiple tissues

J Zhang, Y Liu, Y Chen, L Yuan, H Liu… - Stem Cells …, 2020 - Wiley Online Library
Adipose‐derived stem cells (ADSCs) can maintain self‐renewal and enhanced
multidifferentiation potential through the release of a variety of paracrine factors and …

MSCs vs. iPSCs: Potential in therapeutic applications

K Thanaskody, AS Jusop, GJ Tye… - Frontiers in Cell and …, 2022 - frontiersin.org
Over the past 2 decades, mesenchymal stem cells (MSCs) have attracted a lot of interest as
a unique therapeutic approach for a variety of diseases. MSCs are capable of self-renewal …

Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review

S Shokravi, V Borisov, BA Zaman, F Niazvand… - Stem Cell Research & …, 2022 - Springer
Recently, mesenchymal stromal cells (MSCs) and their derivative exosome have become a
promising approach in the context of liver diseases therapy, in particular, acute liver failure …

Treatment of Alzheimer's disease: beyond symptomatic therapies

FR Buccellato, M D'Anca, GM Tartaglia… - International Journal of …, 2023 - mdpi.com
In an ever-increasing aged world, Alzheimer's disease (AD) represents the first cause of
dementia and one of the first chronic diseases in elderly people. With 55 million people …

[HTML][HTML] Translational insights into stem cell preconditioning: from molecular mechanisms to preclinical applications

K Moeinabadi-Bidgoli, A Babajani… - Biomedicine & …, 2021 - Elsevier
Cell-based therapy (CBT) is a revolutionary approach for curing a variety of degenerative
diseases. Stem cell-based regenerative medicine is a novel strategy for treating tissue …

Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and …

M Rahbaran, AO Zekiy, M Bahramali… - Cellular & Molecular …, 2022 - Springer
Recently, mesenchymal stromal cell (MSC)-based therapy has become an appreciated
therapeutic approach in the context of neurodegenerative disease therapy. Accordingly, a …

Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier

A Shariati, R Nemati, Y Sadeghipour… - European journal of cell …, 2020 - Elsevier
Neurodegenerative disorders are a variety of diseases including Alzheimer's (AD),
Parkinson's (PD), and Huntington's diseases (HD), multiple sclerosis (MS) and amyotrophic …

Mesenchymal stromal cells for the treatment of Alzheimer's disease: Strategies and limitations

S Regmi, DD Liu, M Shen, BD Kevadiya… - Frontiers in Molecular …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a major cause of age-related dementia and is characterized by
progressive brain damage that gradually destroys memory and the ability to learn, which …

Mitochondria-inspired nanoparticles with microenvironment-adapting capacities for on-demand drug delivery after ischemic injury

Y Lin, J Liu, R Bai, J Shi, X Zhu, J Liu, J Guo, W Zhang… - ACS …, 2020 - ACS Publications
Stimuli-responsive nanoparticles (NPs), so-called “smart” NPs, possess great potentials in
drug delivery. Presently, the intelligence of smart NPs is mainly based on their chemical or …

Metabolic determinants of Alzheimer's disease: A focus on thermoregulation

M Tournissac, M Leclerc, J Valentin-Escalera… - Ageing Research …, 2021 - Elsevier
Alzheimer's disease (AD) is a complex age-related neurodegenerative disease, associated
with central and peripheral metabolic anomalies, such as impaired glucose utilization and …